论文部分内容阅读
目的探讨难治性特发性血小板减少性紫癜(ITP)行脾动脉栓塞(PSE)治疗的临床疗效。方法对我院2007年7月～2009年10月15例特发性血小板减少性紫癜内科治疗无效患者行部分脾动脉栓塞(PSE)治疗。于术前及术后1d、3d、1周、2周、1个月、3个月复查血常规。并于术前、术后1个月检测免疫球蛋白,观察其临床疗效。结果 15例患者中有12例显效(80.0%),良效2例(13.3%),无效1例(6.7%)。结论 PSE操作简单,创伤小,并发症少,保留了脾脏的免疫功能,临床疗效满意,是治疗难治性ITP安全有效的方法。
Objective To investigate the clinical efficacy of refractory idiopathic thrombocytopenic purpura (ITP) treated with splenic artery embolization (PSE). Methods Fifteen patients with idiopathic thrombocytopenic purpura in our hospital from July 2007 to October 2009 were treated with partial splenic artery embolization (PSE). Preoperative and postoperative 1d, 3d, 1 week, 2 weeks, 1 month, 3 months to review the blood routine. And in preoperative and postoperative 1 month detection of immunoglobulin, observe its clinical efficacy. Results Of the 15 patients, 12 were markedly effective (80.0%), 2 were good (13.3%) and 1 (6.7%) were ineffective. Conclusions PSE is a simple, safe, and effective method for the treatment of refractory ITP. It has the advantages of simple operation, less trauma and fewer complications, retains the immune function of the spleen and has satisfactory clinical curative effect.